Marksans Pharma LimitedNSE: MARKSANS

Press Release Nov 17 2025

· Issued by Marksans Pharma Limited

Filed with NSE · · 1 page · English

Release

Marksans Pharma Limited has informed the Exchange regarding a press release dated November 17, 2025, titled "Marksans Pharma Limited's wholly owned subsidiary Relonchem Limited receives Marketing Authorisation for its Products from UK MHRA.".

Marksans Pharma Limited on 6ix

Earlier from Marksans Pharma

Later from Marksans Pharma

All Marksans Pharma news releases